|Day Low/High||3.87 / 4.03|
|52 Wk Low/High||2.45 / 10.24|
Conference Call to Discuss the Results at 5:00 p.m. ET
Expects to Complete the Studies Later this Year and Continues to Project Commercial Launch in the First Half of 2017
BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the second quarter ended June 30, 2016 and provided a...
Positive New Data to be Featured in a Poster Discussion
Conference Call to Discuss the Results at 5 p.m. ET
Live Panel Discussion on June 6, 2016 at 4:45pm CT
With small-cap stocks taking a beating this month, some of the worst performers include companies in the shipping, biotech and, of course, energy sectors.
The CEO of Allison Transmission (ALSN) sees some slowing in its North America business, but believes weakness is some of its key markets may have bottomed.
Nielsen said Monday it plans to sell its expositions business to Onex Corp. for $950 million, boosting cash for Arbitron acquisition.
Citigroup may retain a minority stake in its consumer finance business rather than sell the entire franchise as initially planned, according to a news report.